Oxford and AstraZeneca’s COVID vaccine trial could restart ‘within days’
Trials of Oxford University’s coronavirus vaccine could be allowed to restart just days after a British volunteer was rushed to hospital with suspected swelling in their spinal cord. UK drug giant AstraZeneca, which owns the rights to the vaccine, announced that all studies of the jab had been paused indefinitely while it investigates whether the … Read more